Psychedelic Stock Picks Resources

Use these original research and public-information resources to check the claims covered by Psychedelic Stock Picks. Study publication dates and document status matter; inclusion here is not an endorsement of a treatment, company, or security.

Original sources and research tools

• Investor.gov: Stocks
• SEC: Using EDGAR to research investments
• FDA: Clinical research phases
• SEC: Reading a Form 8-K
• FDA: Drug development and approval
• ClinicalTrials.gov: How to read a study record
• SEC EDGAR search
• Investor.gov: Diversification
• FDA June 2023 announcement
• FDA guidance listing
• Goodwin et al., NEJM (2022)
• Raison et al., JAMA (2023)
• Mitchell et al., Nature Medicine (2023)
• ClinicalTrials.gov: How to read study results

How to use these sources

Start with the research question, population, comparison group, and follow-up. Separate planned milestones from results and historical documents from current guidance. Read the limitations and adverse-event reporting alongside favorable findings.

Investment information is educational, not a recommendation to buy or sell securities. Investing involves risk, including loss of capital.